Acenocoumarol

Specifications

152-72-7CAS Number

205-807-3EC Number

4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-2-oneIUPAC Name

C19H15NO6Chemical Formula

353.3 g/molMolecular Weight

ACENOCOUMAROL; 152-72-7; Acenocoumarin; Nicoumalone; Sintrom; Nitrowarfarin; Nitrovarfarian; Sinthrome; Acenocumarol; Nicumalon; Sinkumar; Sincoumar; Ascumar; Syntrom; Zotil; Acenokumarin; Sinthrom; Sintroma; Acenocoumarolum; Acenocumarolo; Mini-sintrom; Acenocumarolum; Nitrophenylacetylethyl-4-hydroxycoumarine; Minisintrom; 3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin; 3-(alpha-Acetonyl-p-nitrobenzyl)-4-hydroxycoumarin; DTXSID2022541; 3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin; 4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one; 3-(alpha-p-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin; 3-(alpha-(p-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin; 4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-2-one; NSC-760052; I6WP63U32H; 4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one; G-23,350; G23350; 4-hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-chromen-2-one; DTXCID802541; CHEBI:53766; 4-Hydroxy-3-[1-(4-Nitrophenyl)-3-oxobutyl]-2H-1-benzopyran-2-one; Coumarin, 3-(alpha-acetonyl-p-nitrobenzyl)-4-hydroxy-; Mini Sintrom; 4-hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)chromen-2-one; (+-)-Acenocoumarol; RefChem:551472; B01AA07; 205-807-3; Syncoumar; Syncumar; Trombostop; Acenocoumarolum [INN-Latin]; Acitrom; Acenocoumarol [INN]; G-23350; G 23350; MFCD00137816; Acenocoumarol (INN); Neositron; 2H-1-Benzopyran-2-one, 4-hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-; C19H15NO6; MLS000539171; SMR000162652; Acenokumarin [Czech]; Acenocumarolo [DCIT]; 2H-1-Benzopyran-2-one, 4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-; Mini-sintrom (TN); HSDB 3201; EINECS 205-807-3; UNII-I6WP63U32H; Acenocoumarol [INN:BAN:NF]; (+/-)-ACENOCOUMARIN; NCGC00016414-01; CAS-152-72-7; Prestwick_773; 1185071-64-0; Opera_ID_1500; Prestwick0_000110; Prestwick1_000110; Prestwick2_000110; Prestwick3_000110; ACENOCOUMAROL [MI]; 3-(a-acetonyl-p-nitrobenzyl)-4-hydroxycoumarin; ACENOCOUMAROL [HSDB]; SCHEMBL33543; BSPBio_000100; AB-014/25000129; MLS001074461; ACENOCOUMAROL [MART.]; SPBio_002039; ACENOCOUMAROL [WHO-DD]; BPBio1_000110; CHEMBL397420; GTPL9015; orb1218756; orb1296137; SCHEMBL1477562; SCHEMBL29454369; DTXSID00991186; Acenocoumarol, >=98% (HPLC); HMS1568E22; HMS2095E22; HMS2232P20; HMS3372J11; HMS3713F17; Pharmakon1600-01502411; HY-B1014; MSK10990; Tox21_110430; EBC-26701; NSC760052; AKOS015962123; Tox21_110430_1; AB03786; AB07575; AB07577; CCG-213077; CS-4527; DB01418; NSC 760052; NCGC00179658-01; NCGC00179658-04; AS-56473; DA-50125; SY237552; A3186; AB00513804; NS00041335; D07064; AB00513804_02; AB00527557-09; EN300-18472689; F827551; Q304088; SR-01000678252; SR-01000678252-3; 3-(.alpha.-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin; 3-(.alpha.-Acetonyl-p-nitrophenyl)-4-hydroxycoumarin; BRD-A65051990-001-03-8; BRD-A65051990-001-12-9; 3-(.alpha.-Acetonyl-p-nitrobenzyl)-4-hydroxy-coumarin; 4-hydroxy-3-[1-(4-nitrophenyl)-3-oxo-butyl]chromen-2-one; Coumarin, 3-(.alpha.-acetonyl-p-nitrobenzyl)-4-hydroxy-; 3-(.ALPHA.-ACETONYL-P-NITROBENZYL)-4-HYDROXYCOUMARIN; 3-(.alpha.-p-Nitrophenyl-.beta.-acetylethyl)-4-hydroxycoumarin; 2-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-4H-1-benzopyran-4-one; 3-(.alpha.-(4-Nitrophenyl)-.beta.-acetylethyl)-4-hydroxycoumarin; 3-(.alpha.-(p-Nitrophenol)-.beta.-acetylethyl)-4-hydroxycoumarin; 4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one #; Acenocoumarol, United States Pharmacopeia (USP) Reference StandardSynonyms